Search clinical trials for: AC-1202

Total 1074 results

Cerecin
Celerion

Completed

Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production

Healthy

United States
Cerecin

Completed

Tricaprilin in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Cerecin

Completed

Tricaprilin In Age-Associated Memory Impairment

Age-Associated Memory Impairment

United States
Cerecin

Completed

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Alzheimer Disease

Australia
Cerecin
Celerion

Completed

Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

Healthy

United States
Cerecin

Withdrawn

Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides

Alzheimer Disease
Cerecin

Terminated

Tricaprilin Liquid Formulation PK Study

Alzheimer Disease

Australia
University of California, Los Angeles
John Douglas French Foundation

Completed

A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease (AD)

Alzheimer Disease

United States
Cerecin
Celerion

Completed

Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production

Healthy

United States
University of Alabama at Birmingham

Terminated

Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL) (CHOP U2)

Mantle Cell Lymphoma

United States
Taipei Medical University WanFang Hospital

Completed

Evaluation of Effects of Clavicular Hook Plate on Subacromial Space

AC Joint Dislocation

Taiwan
TG Therapeutics, Inc.

Terminated

Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials

Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

United States
DualityBio Inc.

Not yet recruiting

A Study of DB-1202 Monotherapy in Advanced Solid Tumors

Advanced Solid Tumor

China
University of Maryland, Baltimore
National Institute on Aging (NIA); Penn State University

Recruiting

Implementation of Function Focused Care in Acute Care

Dementia | Hospitalization | Acute Medical Event

United States
TG Therapeutics, Inc.
SCRI Development Innovations, LLC

Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma

United States
TG Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Non Follicular Indolent Non-Hodgkin Lymphoma

United States
H. Lee Moffitt Cancer Center and Research Institute
TG Therapeutics, Inc.

Terminated

TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

Bladder Cancer

Australia
Cerecin

Completed

Tricaprilin Phase 2 Pilot Study in Migraine

Migraine

Australia
University of Turku

Completed

Arthroscopic Coracoclavicular Ligament Reconstruction Comparing Two Techniques

AC Joint Dislocation

Finland
Columbia University
TG Therapeutics, Inc.

Terminated

TGR1202 in Relapsed and Refractory Follicular Lymphoma

Follicular Lymphoma

United States
University Hospital, Geneva
Swiss HIV Cohort Study

Unknown

Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring (TDM)

HIV Infections | Human Immunodeficiency Virus

Switzerland
Millennium Pharmaceuticals, Inc.

Completed

Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis

Multiple Sclerosis
Weill Medical College of Cornell University
TG Therapeutics, Inc.

Terminated

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Chronic Lymphocytic Leukemia | CLL/SLL | CLL Progression

United States
TG Therapeutics, Inc.

Terminated

A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304

Chronic Lymphocytic Leukemia

United States, Poland, Italy, United Kingdom
Columbia University

Terminated

Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma

Hodgkin Disease | Lymphoma, Non-hodgkin

United States
Baylor Breast Care Center
Baylor College of Medicine

Completed

Biologic Correlative Taxotere/AC (TAX/AC)

Breast Cancer

United States
Cerecin

Withdrawn

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Alzheimer's Disease
Arizona State University
Calm.com, Inc.

Completed

Incentivizing Meditation App Habit Formation

Stress | Adherence, Treatment

United States
University of Nebraska
National Cancer Institute (NCI)

Completed

TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma

United States
Centre Hospitalier Universitaire Dijon

Unknown

Search for Prognostic Factors Associated With Better Survival in Refractory Cardiac Arrest (Pro-ACR)

Cardiac Arrest (CA) | ExtraCorporeal Life Support (ECLS)

France
Genesis Athens Clinic
National and Kapodistrian University of Athens

Recruiting

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders (PRP)

Infertility, Female | Ovary; Anomaly

Greece
Genesis Athens Clinic
National and Kapodistrian University of Athens

Recruiting

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women (PRP)

Menopause | Amenorrhea | Infertility, Female | Anovulatory Infertility

Greece
Eleven Biotherapeutics

Completed

A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis (EBI-005-AC-2)

Allergic Conjunctivitis (AC)

United States
TWi Biotechnology, Inc.

Completed

Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

EGFR Inhibitor-Induced Skin Rash

Taiwan
Shahid Beheshti University of Medical Sciences

Unknown

The Effect of Slanted Recession of Horizontal Muscle on Horizontal Strabismus With Abnormal Accommodative Convergence /Accommodation Ratio (AC/A)

Horizontal Strabismus With High AC/A Ratio

Iran, Islamic Republic of
TWi Biotechnology, Inc.

Completed

A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy

Hemophilic Arthropathy

Taiwan
University of California, San Diego
The San Diego LGBT Community Center

Completed

2nd AC+: New Village Model (2nd AC+)

Aging | Hiv | Loneliness | Social Isolation

United States
CardioFocus

Completed

Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF

Paroxysmal Atrial Fibrillation

Germany
Peregrine Pharmaceuticals

Completed

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer (SUNRISE)

Carcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer Metastatic

United States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
University of Pittsburgh

Recruiting

Dignity, Legacy, Advocacy, and Support for Advanced Cancer: Reimagined End of Life Care in the Black Community (Doulas-AC)

Metastatic Breast Cancer

United States
Asieris Pharmaceutical Technologies Co., Ltd.

Completed

Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment (NMIBC)

Non-Muscle Invasive Bladder Cancer (NMIBC)

United States
Johns Hopkins University

Terminated

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Diabetic Retinopathy | Stargardt Disease | Macular Degeneration (Age Related)

United States
Chugai Pharmaceutical

Unknown

CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC (QUATTRO-II)

Metastatic Colorectal Cancer

Japan
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (ANTICIPATE)

Muscle Invasive Bladder Cancer

United States, China
Indiana University
National Institute of Mental Health (NIMH); Yale University; University of Michigan and other collaborators

Recruiting

Academic-Community EPINET (AC-EPINET) (AC-EPINET)

Schizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Schizophreniform Disorders | Bipolar Disorder With Psychotic Features

United States
University of Chicago

Active, not recruiting

Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL

CLL | B-cell Non Hodgkin Lymphoma

United States
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Completed

Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy

Non-muscle Invasive Bladder Cancer
POINT Biopharma, a wholly owned subsidiary of Eli...
Eli Lilly and Company

Recruiting

[Ac-225]-PSMA-62 Trial in Biochemically Recurrent and Metastatic Castration Resistant Prostate Cancer (ACCEL)

Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | Metastatic Castration-resistant Prostate Cancer

Canada
Hvidovre University Hospital

Completed

Acute Acromioclavicular Dislocation: Epidemiology, Natural History and Analysis of Prognostic Factors

Acromioclavicular Joint Dislocation

Denmark

Search clinical trials for: AC-1202

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations